GTC Biotherapeutics (fka GTCB)

[ThomasS]

More Factor VII: Maxygen-MAXY receives approval for clinical trial of Factor Vlla in UK
Maxygen announced that it has filed a Clinical Trial Authorization and received the necessary approvals in the United Kingdom to initiate a first-in-human Phase I trial of MAXY-VII in hemophilia patients. MAXY-VII is the company's next-generation Factor VIIa protein for the treatment of hemophilia. Patient dosing is on schedule to begin in the second half of this year. :theflyonthewall.com